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Conclusions: Canonical wnt expression and subsequent WISP1 is increased
in the synovium during experimental OA. This synovial expression may
lead to the degradation of cartilage, possibly by change of the articular
chondrocyte phenotype. This change of chondrocyte phenotype may be
induced by change of the TGFβ signaling route from the smad2P route to
the smad1,5,8 route. Canonical wnt signaling stabilizes smad1,5,8, whereas
WISP1 has been shown to inhibit smad2 phosphorylation (Inkson et al. J
Cell. Biochem. 2008). This indicates synovial wnt expression as a potential
target for OA therapy.
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Purpose: Recent case-control studies have shown an association between
type 3 ﬁnger length pattern (longer ring ﬁnger than index ﬁnger) and knee
osteoarthritis. This study tests the hypothesis that the type 3 pattern is
associated with total joint replacements (TJR) due to osteoarthritis in a
large population based study.
Methods: In this population-based multidisciplinary study of aging in the
elderly population of Reykjavik, Iceland, the prevalence of OA caused TKR
was 223 (4.3%) and THR 316 (6.1%). Finger length ratios were assessed
visually on 5170 hand photographs (2975 females, 2195 males, mean age
76±6 years). For comparison, similar visual readings were done with 371
hand radiographs (211 females, 160 males mean age 75.6±4.8) from the
same group. Exact (pixel) measures of the ﬁngers and metacarpals were
also obtained in this sample.
Results: Visual assessments of ﬁnger lengths overestimated the pixel 2D:4D
ratio which was on average 0.91±0.02 and less than 1 in all cases. Accord-
ing to visual assessments of the radiographs, 64% had type 3 pattern (54%
in females, 78% in males). Visual assessment of photographs had an even
lower prevalence of the type 3 pattern 50% (43% in females 58% in males).
In the photographic assessment there were associations with age (higher
prevalence of type 3 pattern) height (lower prevalence) and metacarpal 2:4
ratio (lower prevalence). Correlation between the two methods was 0.65.
We then performed a backwards binary logistic regression analysis for
TKR and THR, including ﬁnger length patterns, OA at other sites and other
variables with possible association to OA such as age, gender, abdominal
circumference, BMI, hs-CRP, cholesterol, statin use, bone mineral density of
the spine, education and smoking history. The regression analysis revealed
an odds ratio for TKR of 1.65 (1.24-2.2) p=0.0007, in the type 3 ﬁnger
pattern group, similar in both genders. No association was seen between
ﬁnger length patterns and THR. In the much smaller radiography sample,
unadjusted OR for TKR was 1.9 (0.6-5.8) in the type 3 ﬁnger group, not
signiﬁcant.
Conclusions: Finger length patterns can be read from digital photographs
but the method seems to underestimate the prevalence of type 3 ﬁnger
length pattern compared with radiographic readings. It may also be con-
founded by age, height and metacarpal ratio. Nevertheless there is a clearly
signiﬁcant association between the type 3 pattern and TKR but not THR in
both genders in this elderly group.
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REQUIREMENT OF SYNOVIAL PERLECAN FOR OSTEOPHYTE FORMATION
IN OSTEOARTHRITIS
H. Kaneko1,2, M. Ishijima1,2, I. Futami1,2, N. Ichikawa3,
E. Hirasawa-Arikawa3, K. Kaneko1,2
1Dept. of Med. for Motor Organ, Juntendo Univ. Graduate Sch. of Med., Tokyo,
Japan; 2Dept. of orthopedics, Juntendo Univ. Sch. of Med., Tokyo, Japan; 3Res.
Inst. for Disease of Old Age, Juntendo Univ., Graduate Sch. of Med., Tokyo,
Japan
Purpose: Osteoarthritis (OA) is primarily characterized by cartilage degra-
dation. However, osteophyte formation, as well as subchondral bone
sclerosis, cysts, and synovial inﬂammation, are also observed in the de-
velopment of OA. The osteophyte, which is one of the signs of severe
OA, is a bony outgrowth at the margins of the joint. Transforming growth
factor (TGF)-β is involved in this process. However, its precise molecular
mechanisms still remain unclear.
Perlecan is a heparan sulfate proteoglycan present in all basement mem-
branes, cartilage and synovium. Perlecan interacts with extracellular matrix
proteins, growth factors, and receptors, and is implicated in cell growth,
differentiation, and signaling. Functional null-mutations of perlecan cause
lethal chondrodysplasia in both mice and humans (Dyssegmental dysplasia,
Silverman-Handmaker type (DDSH)). Although perlecan is required for the
development of cartilage, the roles of perlecan in synovial tissues and
in the development of OA are unknown. The purpose of this study was
to investigate the role of perlecan expressed in synovial tissues in the
development of knee OA.
Methods: The perlecan-null (Perl-/-) mice die perinatally because of prema-
ture cartilage development. To restore cartilage abnormalities, we created
the lethality-rescued mice (Perl-/-;Col2-TgPerl) by mating heterozygous
perlecan-null (Perl+/-) mice with transgenic (Col2-TgPerl) mice, which ex-
pressed recombinant perlecan in cartilage using a cartilage-speciﬁc Col2a1
promoter. In intra-articular tissues of Perl-/-;Col2-TgPerl mice, perlecan was
expressed in chondrocytes but not in the synovium. Hetrozygous perlecan
null mice with the transgene (Perl+/-;Col2-TgPerl) were used as control. Two
procedures were used to induce knee OA in 12-week-old female mice.
Study1 (instability model): Left knee joints of the mice were subjected to
surgical induction of OA by the transduction of medial collateral ligament
and resection of medial meniscus, while right knee joints of the mice were
subjected to sham-operation by capsulectomy. Study2 (TGF-β model): Left
knee joints of the mice were injected i.a. with TGF-β (200 ng) three times
on alternate days. The mice were sacriﬁced at 1, 2, 4 and 8 weeks after
either the surgery or the injection. The development of OA in the mice was
histologically evaluated.
Results: In Perl-/-;Col2-TgPerl mice, perlecan was expressed in the pericellu-
lar matrix of chondrocytes in both articular cartilage and growth plates, but
not in the lining or sublining layers of synovial tissues, while control mice
expressed perlecan in all these tissues. In the Study1 OA model, the medial
side of the left knee joints in both control and Perl-/-;Col2-TgPerl mice
resulted in the OA exhibiting cartilage destruction, osteophyte formation,
and synovial inﬂammation 4 weeks after surgery, while the right knees
did not show any changes. There were no signiﬁcant differences in scores
of cartilage destruction and synovitis of the joints in Perl-/-;Col2-TgPerl
and control mice. However, the osteophyte size and maturation in the
joints were signiﬁcantly reduced in Perl-/-;Col2-TgPerl mice compared with
those in control mice (p<0.05). In the Study2 OA model, osteophytes were
induced by TGF-β in both Perl-/-;Col2-TgPerl and control mice, similar to
that observed in the Study1 OA model. However, the size and maturation
of osteophytes in Perl-/-;Col2-TgPerl mice were also signiﬁcantly reduced
compared with those in control mice (p<0.05).
Conclusion: Our study using two different in vivo OA models demonstrates
that the osteophyte formation in OA is inhibited due to the absence of
perlecan in the synovium. Thus perlecan in the synovium is critical to
osteophyte formation, probably through TGF-β signaling.
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R-SPONDINS ARE NEW PLAYERS IN OSTEOARTHRITIS THAT REGULATE
WNT SIGNALING IN OSTEOBLASTS
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Purpose: Clinical and in vitro studies suggest that subchondral bone scle-
rosis and altered bone remodeling, due to abnormal osteoblasts (Ob), is
involved in the progression and/or onset of osteoarthritis (OA). Moreover,
human OA subchondral Ob show a phenotype of very differentiated cells,
however they fail to mineralize normally in vitro as in vivo. Wnt signaling
plays a key role in osteogenesis by promoting the differentiation and
mineralization of Ob mainly via the canonical Wnt/β-catenin signaling
pathway. R-spondins (Rspo), a new family of 4 proteins structurally unre-
lated to other Wnt ligands, can act as Wnt agonists and in particular they
can oppose the inhibition of Wnt/β-catenin signalling by Dickkopf-1 and
-2. Two of the Rspo family members are present in bone tissues, Rspo1
and Rspo2, yet we still have no data on their potential role in OA. Here
we investigated the presence of Rspo-1 and -2, their potential upstream
effectors, and their role in OA Ob.
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Methods: We prepared primary human subchondral osteoblasts using the
sclerotic medial portion of the tibial plateaus of OA patients undergoing
total knee arthroplasty, or from tibial plateaus of normal individuals at au-
topsy. The expression of Rspo-1 and -2 was evaluated by qRT-PCR and their
protein production by Western blot analysis. Wnt/β-catenin signaling was
evaluated using two approaches: 1) target gene expression was measured
using the TOPﬂash TCF/lef luciferase reporter assay, and 2) intracellular
signaling partners β-catenin, phospho β-catenin, GSK3β and phospho GSK3β
levels were evaluated by Western blot analysis. Mineralization in response
to Wnt3a in presence or not of Rspo-2 was evaluated by Alizarin red
staining.
Results: Rspo-1 expression was similar in normal and OA Ob. In contrast,
the expression of Rspo-2 was reduced in OA samples compared to normal.
Similarly, Western blot analysis revealed that Rspo-2 was reduced in OA
Ob compared to normal. TGF-β1 reduced Rspo-2 expression and produc-
tion whereas BMP-2 increased them. Wnt3a-dependent TOPﬂash TCF/lef
reporter assay was reduced in OA Ob compared to normal. Recombinant
human Rspo-2 alone failed to trigger Wnt signaling in OA Ob measured
using the TOPﬂash reporter assay however, it stimulated about two-fold
the Wnt3a-dependent response in these cells. Likewise, β-catenin levels
which increased in presence of Wnt3a alone were further increased by
Rspo-2 treatment. Rspo2 treatments also modulated the Wnt3a-dependent
phospho GSK3β response of OA Ob. Wnt3a alone increased the basal
mineralization of OA Ob and although Rspo-2 alone failed to modify the ab-
normal mineralization of OA Ob, it further increased the Wnt3a-dependent
mineralization of OA Ob.
Conclusions: These data demonstrate for the ﬁrst time that Rspo-2 is a new
key player in abnormal OA Ob function. Reduced Rspo-2 levels in OA Ob
are responsible, at least in part, for their reduced Wnt/β-catenin signaling
and abnormal mineralization. As Rspo-2 is a secreted soluble protein, this
could lead to potential new avenues of treatment of OA to correct their
abnormal bone phenotype and mineralization.
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Purpose: Chondrogenically differentiated human mesenchymal stromal
cells (hMSCs) are prone to undergo endochondral ossiﬁcation. Under nor-
mal circumstances, this process is limited to growth plate cartilage (GP)
but not articular cartilage (AC). The molecular mechanisms that prevent AC
from terminal differentiation and ossiﬁcation are largely unknown.
Our key objectives were i) to identify genetic markers that distinguish
AC from GP, and ii) to identify molecular mechanisms that prevent AC
from endochondral ossiﬁcation. We hypothesized that this information can
be utilized to optimize tissue engineering strategies to obtain AC from
differentiating hMSCs.
Methods: Gene expression proﬁles of healthy AC and GP from the same
patients were compared in a genome wide micro-array study. Protein
expression was investigated for three articular enriched genes using Im-
munohistochemistry on AC and GP. Recombinant proteins of the same three
articular enriched genes were added to chondrogenically differentiating
hMSCs to investigate their effect on hypertrophic differentiation.
Results: We identiﬁed differential expression of 2915 genes between GP
and AC, from which we generated a marker-set able to distinguish the two
hyaline cartilage subtypes. Furthermore, we showed that differentiating
MSCs acquire a genetic ﬁngerprint resembling GP, but not AC.
Interestingly, the three most differentially expressed genes, being enriched
in the AC, are Wnt- and BMP antagonists: FRZb, DKK1 and Gremlin1.
Immunohistochemistry demonstrated the presence of these antagonists
throughout the entire AC. In the GP their expression was mainly restricted
to the resting zone.
Chondrogenically differentiated hMSCs did not express the 3 antagonists
and underwent hypertrophic differentiation. Remarkably, the addition of
recombinant Grem1, FRZb or DKK1 did not affect chondrocyte differentia-
tion but prevented their hypertrophic differentiation.
Conclusions: Micro-array analysis has identiﬁed genetic ﬁngerprints highly
speciﬁc for the two types of hyaline cartilage, GP and AC, which can be
used to optimize tissue engineering strategies. We have identiﬁed the
Wnt- and BMP-antagonists, FRZb, DKK1 and Grem1 as speciﬁc markers
for AC. We show that these antagonists prevent hypertrophic chondrocyte
differentiation.
Our data suggest that Wnt- and BMP-antagonists play a prominent role in
establishing a joint micro-environment, which prevents AC from undergo-
ing endochondral ossiﬁcation.
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MOLECULAR NETWORK ON THE C/EBP-BETA AXIS INCLUDING RUNX2,
MMP13, AND HIF2A CONTROLS OSTEOARTHRITIS DEVELOPMENT
M. Hirata1,2, F. Kugimiya1, A. Fukai1, T. Saito1, F. Yano2, T. Ikeda1,
K. Nakamura1, U.-i. Chung2, H. Kawaguchi1
1The Univ. of Tokyo, Sensory & Motor System Med., Tokyo, Japan; 2The Univ.
of Tokyo, Ctr. for Disease Biology and Integrative Med., Tokyo, Japan
Purpose: CCAAT/enhancer-binding protein β (C/EBPβ) is a crucial tran-
scription factor for chondrocyte differentiation and cartilage degradation
in the process of endochondral ossiﬁcation during skeletal growth. Since
the endochondral ossiﬁcation process is also known to be important for
osteoarthritis (OA) development, this study examined the role of C/EBPβ in
OA development and explored the related molecular network.
Methods: We performed histological analyses of homozygous (-/-) or het-
erozygous (+/-) deﬁcient mice in comparison with the wild-type littermates.
An experimental OA model was created surgically by inducing instability
in the knee joints of 8-week-old mice, and OA severity was quantiﬁed by
the OARSI histopathology grade. Human joint cartilage was obtained as
surgical specimens of total knee arthroplasty. For functional analyses, we
created stable lines of human chondrogenic SW1353 cells with retroviral
overexpression of the genes, and evaluated the endogenous expression of
target genes by real-time RT-PCR. Screenings of upstream and downstream
signals were performed using SW1353 and human non-chondorogenic
HeLa cells transfected with luciferase-reporter constructs containing the
promoters. For comprehensive promoter analyses, we performed luciferase
assay, electrophoretic mobility shift assay (EMSA), and chromatin immuno-
precipitation assay involving sequential immunoprecipitation (ChIP-reIP)
using SW1353 and HeLa cells.
Results: The C/EBPβ expression increased with OA development in the
knee joint cartilages of the mouse experimental model and human sur-
gical specimens. This expression was co-localized with Runx2, another
key transcription factor for endochondral ossiﬁcation. Although C/EBPβ-/-
mice exhibited severe dwarﬁsm and Runx2-/- mice were embryonically
lethal, both C/EBPβ+/- mice and Runx2+/- mice grew normally under
physiological conditions. Under the OA induction, however, both +/- mice
showed resistance to joint cartilage degradation with decreased expres-
sions of endochondral ossiﬁcation markers like COL10A1, ADAMTS4, 5,
and MMP3, 9, 13, as compared to respective wild-type littermates. To
know the molecular interaction, we generated the compound heterozygous
deﬁcient (C/EBPβ+/-;Runx2+/-) mice. Although the C/EBPβ+/-;Runx2+/- mice
grew nornally, the resistance to OA development and decreases of the
endochondral ossiﬁcation markers were more enhanced than C/EBPβ+/-
or Runx2+/- littermates. Among the endochondral ossiﬁcation markers,
co-transfection of C/EBPβ and Runx2 most strongly enhanced promoter
activity and endogenous expression of MMP13. Analyses of the MMP13
promoter by luciferase assays identiﬁed the core responsive element as
being located between the -144 and -89 bp region containing a C/EBP-
binding motif (-103/-99) and a Runx-binding motif (-138/-132). Speciﬁc
and direct bindings of C/EBPβ and Runx2 proteins to respective motifs
were conﬁrmed by EMSA and ChIP-reIP assay. Interestingly, the binding of
C/EBPβ or Runx2 was blocked only when mutations were created in both
motifs, but not by mutagenesis in either motif alone, indicating that these
factors bind to respective motifs as a protein complex. We then explored
the upstream signal using theC/EBPβ promoter assay among transcription
factor families that are known to regulate chondrocyte differentiation, such
as Sox, Runx, other C/EBP, MEF2, SP/KLF, ATF, NF-κB, and hypoxia-inducible
factor (HIF); and identiﬁed HIF2A as the most potent transactivator of
C/EBPβ. Our further promoter analyses in the C/EBPβ promoter identiﬁed a
hypoxia-responsive element (HRE) motif (-69/-65) as the core responsive
region.
Conclusions: C/EBPβ plays a central role in cartilage degradation during OA
development by forming a molecular network with Runx2 as the co-factor,
MMP13 as the target, and HIF2A as the inducer. This signal on the C/EBPβ
axis may represent a therapeutic target for OA.
